Results 251 to 260 of about 1,542,280 (335)

Shared care for chronic eye diseases: perspectives of ophthalmologists, optometrists and patients

open access: green, 2012
Patricia O’Connor   +5 more
openalex   +1 more source

Your Eyes and Their Care [PDF]

open access: yesBritish Journal of Ophthalmology, 1985
openaire   +2 more sources

Designing Physical Unclonable Functions From Optically Active Materials

open access: yesAdvanced Materials, EarlyView.
Assigning unforgeable “fingerprints” to manufactured goods is a key strategy to fight global counterfeiting. Optical physical unclonable functions (PUFs) are chemically generated random patterns of optically active materials serving as unique authenticators.
Maxime Klausen   +2 more
wiley   +1 more source

Barriers and enablers of access to diabetes eye care in Auckland, New Zealand: a qualitative study. [PDF]

open access: yesBMJ Open
Silwal PR   +6 more
europepmc   +1 more source

Engineered Plasmonic and Fluorescent Nanomaterials for Biosensing, Motion, Imaging, and Therapeutic Applications

open access: yesAdvanced Materials, EarlyView.
A schematic illustration of how noble metals can be used to create nanoparticles (NPs) or nanoclusters (NCs). Noble metal NPs, due to their plasmonic properties, enable photothermal therapy and surface‐enhanced Raman scattering (SERS). In contrast, NCs, which lack a plasmonic resonance band, exhibit fluorescence, making them ideal for bioimaging ...
David Esporrín‐Ubieto   +3 more
wiley   +1 more source

Artesunate Nanoplatform Targets the Serine–MAPK Axis in Cancer‐Associated Fibroblasts to Reverse Photothermal Resistance in Triple‐Negative Breast Cancer

open access: yesAdvanced Materials, EarlyView.
The artesunate nanoplatform selectively targets ECM CAF, functioning as a GTPase inhibitor through disruption of intracellular serine homeostasis. This metabolic intervention effectively suppresses MAPK cascade activity, which consequently inhibits PTT‐induced CAF to ECM CAF differentiation.
Dongdong Zheng   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy